酸和酸的生理作用:对与代谢功能障碍相关的脂肪性肝病的影响
Zhili Cheng1, Magdalene K Montgomery1
1Department of Anatomy and Physiology, School of Biomedical Sciences, Faculty of Medicine Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC, 3010, Australia.
酸和酸 (IPs) 是肝脏新陈代谢中的关键信号分子. 它们的新陈代谢失调有助于代谢功能障碍相关的脂肪性肝病 (MASLD),并提供治疗点.
科学领域:
- 细胞信号传递和脂质代谢
- 肝脏病理生理学和代谢性疾病
背景情况:
- 酸和酸 (IPs) 是关键的脂质介质,调节细胞过程,如膜运输和信号传导.
- 最近的研究强调了它们在代谢平衡中的作用以及代谢功能障碍相关的脂肪性肝病 (MASLD) 的发展.
研究的目的:
- 审查关键酸和IPs的合成途径和生理功能.
- 探索这些分子在肝脏代谢中的新兴意义及其对MASLD的贡献.
- 突出针对MASLD的内醇代谢的治疗策略.
主要方法:
- 文献综述综合了当前关于酸和IP代谢的知识.
- 分析研究的分析,研究伊诺西托尔代谢在肝功能和MASLD病变发生中的作用.
- 对MASLD的遗传模型和药理干预措施的检查.
主要成果:
- 酸和IPs调节各种细胞功能,包括肝脏中的代谢途径.
- 异位醇代谢的乱与MASLD的进展,肝炎,纤维化和胰岛素抵抗有关.
- 遗传学和药理学研究表明,针对MASLD治疗的内醇代谢有希望.
结论:
- 酸和IP是肝脏病理生理学中代谢线索的中心整合剂.
- 了解内醇代谢可以了解MASLD的发展和进展.
- 向因诺醇代谢是管理MASLD的潜在治疗途径.
更多相关视频
09:22Absolute Quantitation of Inositol Pyrophosphates by Capillary Electrophoresis Electrospray Ionization Mass Spectrometry
Published on: August 13, 2021
08:07Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry
Published on: July 26, 2019
相关概念视频
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Synthesis of Phosphatidylcholine in the ER Membrane
The major components of all eukaryotic cell...
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
IP3/DAG Signaling Pathway
